Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8667 |
High Similarity |
NPD7819 |
Suspended |
0.8623 |
High Similarity |
NPD7075 |
Discontinued |
0.858 |
High Similarity |
NPD6959 |
Discontinued |
0.8488 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8485 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8448 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8443 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.843 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.843 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.843 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8391 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8391 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8391 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8383 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8362 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8362 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8343 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8343 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8343 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8314 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8304 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8294 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8249 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8225 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8222 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8202 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8192 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8192 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8155 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8146 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8122 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8114 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8072 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8072 |
Intermediate Similarity |
NPD2533 |
Approved |
0.807 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.807 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8049 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8033 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7979 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7977 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7964 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7939 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7927 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7921 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7921 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7919 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7906 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7882 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7879 |
Intermediate Similarity |
NPD2800 |
Approved |
0.787 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7866 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7805 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7798 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7772 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6777 |
Approved |
0.773 |
Intermediate Similarity |
NPD6651 |
Approved |
0.772 |
Intermediate Similarity |
NPD7697 |
Approved |
0.772 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.772 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7706 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7697 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD2796 |
Approved |
0.768 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.768 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7674 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7653 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD37 |
Approved |
0.7636 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7636 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7614 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7614 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7598 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7598 |
Intermediate Similarity |
NPD5711 |
Approved |
0.759 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7577 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD920 |
Approved |
0.7554 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7552 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7538 |
Intermediate Similarity |
NPD7801 |
Approved |
0.753 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD1607 |
Approved |
0.75 |
Intermediate Similarity |
NPD1240 |
Approved |
0.75 |
Intermediate Similarity |
NPD6273 |
Approved |
0.75 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7474 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.743 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD919 |
Approved |
0.7425 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7412 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7401 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7378 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7349 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7341 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7333 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7295 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7268 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7257 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7251 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7246 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7234 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7186 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7186 |
Intermediate Similarity |
NPD943 |
Approved |
0.7186 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7186 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7165 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7157 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7129 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7129 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.71 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.71 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7098 |
Intermediate Similarity |
NPD4287 |
Approved |
0.709 |
Intermediate Similarity |
NPD6764 |
Approved |
0.709 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7087 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7072 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7072 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7048
|
Intermediate Similarity |
NPD8366 |
Approved |